HER3, but Not HER4, Plays an Essential Role in the Clinicopathology and Prognosis of Gastric Cancer: A Meta-Analysis.
Human epidermal growth factor receptor (HER) family plays an important role in gastric cancer (GC), especially HER2. Too much attention has been paid to HER2; however, the functions of HER3 and HER4 overexpression in GC are always ignored. The clinicopathological and prognostic roles of HER3 and HER...
Main Authors: | Guo-Dong Cao, Ke Chen, Mao-Ming Xiong, Bo Chen |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2016-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4990181?pdf=render |
Similar Items
-
Expression of Concern: HER3, but Not HER4, Plays an Essential Role in the Clinicopathology and Prognosis of Gastric Cancer: A Meta-Analysis.
by: PLOS ONE Editors
Published: (2023-01-01) -
Positive prognostic value of HER2-HER3 co-expression and p-mTOR in gastric cancer patients
by: Guo-dong Cao, et al.
Published: (2017-12-01) -
Clinicopathological features and prognosis of patients with HER2-low breast cancer
by: Xin Yang, et al.
Published: (2023-09-01) -
Can HER2 1+ Breast Cancer Be Considered as HER2-Low Tumor? A Comparison of Clinicopathological Features, Quantitative HER2 mRNA Levels, and Prognosis among HER2-Negative Breast Cancer
by: Lan Shu, et al.
Published: (2022-08-01) -
Her2-Positive and Microsatellite Instability Status in Gastric Cancer—Clinicopathological Implications
by: Ana Bermúdez, et al.
Published: (2021-05-01)